| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.81B | 18.91B | 11.25B | 13.80B | 11.57B | 9.80B |
| Gross Profit | 9.40B | 8.01B | 4.09B | 5.58B | 4.84B | 4.38B |
| EBITDA | 8.33B | 6.63B | 4.61B | 7.42B | 6.35B | 5.17B |
| Net Income | 5.76B | 4.96B | 2.47B | 4.83B | 4.10B | 3.38B |
Balance Sheet | ||||||
| Total Assets | 42.19B | 36.94B | 31.86B | 32.12B | 28.29B | 19.87B |
| Cash, Cash Equivalents and Short-Term Investments | 5.42B | 9.44B | 10.50B | 11.14B | 8.03B | 1.70B |
| Total Debt | 4.24B | 1.78B | 2.40B | 3.24B | 4.28B | 5.05B |
| Total Liabilities | 7.67B | 5.36B | 4.29B | 6.24B | 6.97B | 7.27B |
| Stockholders Equity | 34.52B | 31.59B | 27.57B | 25.88B | 21.32B | 12.60B |
Cash Flow | ||||||
| Free Cash Flow | -5.86B | 605.75M | 1.19B | 4.84B | 2.71B | -872.24M |
| Operating Cash Flow | 1.07B | 3.68B | 2.97B | 6.39B | 3.64B | 2.09B |
| Investing Cash Flow | -7.69B | -3.12B | -1.78B | -1.56B | -932.88M | -2.96B |
| Financing Cash Flow | 1.09B | -1.62B | -1.86B | -1.70B | 3.59B | 948.34M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥64.04B | 8.01 | ― | 2.02% | -4.42% | 10.23% | |
74 Outperform | ¥109.95B | 7.90 | ― | 4.18% | 1.16% | 167.89% | |
72 Outperform | ¥82.54B | 14.34 | ― | 1.38% | 47.56% | 49.58% | |
71 Outperform | ¥123.36B | 15.09 | ― | 1.81% | -0.52% | 5.18% | |
68 Neutral | ¥73.61B | 11.90 | ― | 3.75% | -0.68% | -9.93% | |
66 Neutral | ¥17.47B | 9.23 | ― | 3.28% | 13.09% | 89.45% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Tri Chemical Laboratories Inc. reported its consolidated financial results for the nine months ended October 31, 2025, showing significant growth in net sales and profits compared to the previous year. The company achieved a 37.4% increase in net sales and a 30.2% rise in operating profit, indicating strong operational performance and market demand. Additionally, the company’s total assets increased, reflecting a robust financial position. The inclusion of a new subsidiary, AD-Trichem (Anhui) Electronic Materials Co., Ltd., highlights the company’s expansion efforts in the electronic materials sector.
Tri Chemical Laboratories Inc. has announced the execution of a term-loan agreement and a commitment-line agreement to fund the construction of a new plant in Minami-Alps City, Yamanashi Prefecture. These agreements, totaling 10 billion yen, are designed to secure the necessary capital for growth and expansion, with minimal expected impact on the company’s current fiscal performance.